FOXM1 and cardiac hypertrophy: Despite a propensity for aging-mediated cardiac hypertrophy when cardiomyocyte-derived Foxm1 is absent, Foxm1 is not a mediator of the timeline or extent of cardiac hypertrophy or remodeling following aortic banding.